Cite
HARVARD Citation
Tso, J. et al. (2015). Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide. Molecular cancer. 14 (1), pp. 1-17. [Online].